MEOBFMesoblast Ltd.

About Mesoblast Ltd. (MEOBF)

Mesoblast Ltd. (MEOBF) is a company headquartered in Melbourne, VA, Australia whose shares trade over-the-counter on the Pink tier.

Mesoblast is developing a series of high margin, off-the-shelf adult stem cell products that are obtained from a single donor, commercially expanded and frozen, and subsequently used in potentially thousands of unrelated, or allogeneic, recipients at the time and place of need.

MEOBF key facts

Ticker symbol

MEOBF

Market tier

Pink

Headquarters

Melbourne, VA, Australia

Country of incorporation

AU

Estimated market cap

$400.28M (as of May 13, 2025)

Shares outstanding

280,425,300

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

6/30

Mesoblast Ltd. leadership

• Silviu Itescu — CEO
• Paul Rennie — COO
• Jenni Pilcher — CFO
• Julie Meldrum — Director, Corp. Comm.

Explore more: Pink stocks · OTC stocks starting with M